Cigna Group (NYSE:CI) Price Target Raised to $304.00

Cigna Group (NYSE:CIFree Report) had its target price raised by Deutsche Bank Aktiengesellschaft from $301.00 to $304.00 in a research note issued to investors on Tuesday morning, MarketBeat.com reports. They currently have a buy rating on the health services provider’s stock.

A number of other research analysts also recently commented on the stock. Leerink Partners increased their price target on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. UBS Group restated a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a research report on Monday. Mizuho set a $325.00 price objective on Cigna Group in a research note on Friday, January 9th. Truist Financial set a $338.00 target price on Cigna Group in a research report on Monday. Finally, Sanford C. Bernstein restated a “market perform” rating and issued a $307.00 price target on shares of Cigna Group in a research report on Tuesday, January 6th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and an average target price of $330.00.

View Our Latest Research Report on CI

Cigna Group Stock Performance

NYSE CI opened at $287.53 on Tuesday. The stock has a market capitalization of $76.81 billion, a PE ratio of 12.96, a P/E/G ratio of 1.02 and a beta of 0.27. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The business has a 50 day simple moving average of $276.33 and a two-hundred day simple moving average of $283.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.76.

Cigna Group (NYSE:CIGet Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s dividend payout ratio is currently 27.23%.

Institutional Trading of Cigna Group

Several institutional investors have recently modified their holdings of CI. Harbor Capital Advisors Inc. raised its stake in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after acquiring an additional 49 shares in the last quarter. Beacon Financial Strategies CORP purchased a new position in Cigna Group during the 4th quarter worth approximately $28,000. Solstein Capital LLC purchased a new position in Cigna Group during the 2nd quarter worth approximately $29,000. Chilton Capital Management LLC acquired a new position in Cigna Group during the second quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC lifted its stake in Cigna Group by 115.6% in the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after buying an additional 52 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.